Showing results (2481-2490 of 2,940) with videos related to
Sort By:
Pageof 294
Cancer Investigation|September 18, 2008
Do single nucleotide polymorphisms in xenobiotic metabolizing genes determine breast cancer susceptibility and treatment outcomes?Virendra Singh, Devendra Parmar, Mahendra Pratap SinghCancer Investigation|September 18, 2008
Correlation between IL-10 gene expression and HPV infection in cervical cancer: a mechanism for immune response escapeVictor H Bermudez-Morales, Lourdes X Gutierrez, Juan M Alcocer-Gonzalez, et al.Cancer Investigation|September 18, 2008
Gemcitabine combined with gefitinib in patients with inoperable or metastatic pancreatic cancer: a phase II Study of the Hellenic Cooperative Oncology Group with biomarker evaluationGeorge Fountzilas, Mattheos Bobos, Anna Kalogera-Fountzila, et al.Cancer Investigation|September 18, 2008
Can the lack of HSP90alpha protein in brain normal tissue and cell lines, rationalise it as a possible therapeutic target for gliomas?Amal Shervington, Nichola Cruickshanks, Robert Lea, et al.Cancer Investigation|January 1, 1991
Overview of monoclonal antibodies in the diagnosis and therapy of cancerL Vaickus, K A FoonCancer Investigation|June 28, 2008
Induction of the human heat shock promoter HSP70B by nutritional stress: implications for cancer gene therapyFarzan Siddiqui, Paul R Avery, Chuan-Yuan Li, et al.Cancer Investigation|June 28, 2008
FOLFOX-4 regimen with concomitant highly active antiretroviral therapy in metastatic colorectal cancer HIV-infected patients: a report of five cases and review of the literatureMassimiliano Berretta, Fabrizio Di Benedetto, Alessandra Bearz, et al.Cancer Investigation|June 28, 2008
Prognostic factors that determine the long-term survival of patients with unresectable metastatic melanomaAgop Y Bedikian, Marcella M Johnson, Carla L Warneke, et al.Cancer Investigation|June 24, 2008
The emperor's new clothes or the current practice of clinical trials for multiple myeloma in the USAOscar BallesterCancer Investigation|June 24, 2008
Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances anti-tumor responses of peripheral blood mononuclear cells from human lung cancer patientsTao Ren, Zhen-Ke Wen, Zhong-Min Liu, et al.Pageof 294